Screening for hemochromatosis: recommendation statement
- PMID: 16880462
- DOI: 10.7326/0003-4819-145-3-200608010-00008
Screening for hemochromatosis: recommendation statement
Abstract
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hemochromatosis and the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and on the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2006, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methods. The recommendation statement in this paper is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.
Comment in
-
Summaries for patients. Screening for hemochromatosis: recommendations from the U.S. Preventive Services Task Force.Ann Intern Med. 2006 Aug 1;145(3):I18. doi: 10.7326/0003-4819-145-3-200608010-00002. Ann Intern Med. 2006. PMID: 16880456 No abstract available.
Similar articles
-
Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2007 Mar 6;146(5):361-4. Ann Intern Med. 2007. PMID: 17339621
-
Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.Ann Intern Med. 2006 Aug 1;145(3):209-23. doi: 10.7326/0003-4819-145-3-200608010-00009. Ann Intern Med. 2006. PMID: 16880463 Review.
-
Summaries for patients. Screening for hemochromatosis: recommendations from the U.S. Preventive Services Task Force.Ann Intern Med. 2006 Aug 1;145(3):I18. doi: 10.7326/0003-4819-145-3-200608010-00002. Ann Intern Med. 2006. PMID: 16880456 No abstract available.
-
Screening for family and intimate partner violence: recommendation statement.Ann Intern Med. 2004 Mar 2;140(5):382-6. doi: 10.7326/0003-4819-140-5-200403020-00014. Ann Intern Med. 2004. PMID: 14996680
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Ann Intern Med. 2005 Sep 6;143(5):355-61. doi: 10.7326/0003-4819-143-5-200509060-00011. Ann Intern Med. 2005. PMID: 16144894 Review.
Cited by
-
Twenty-Five Years of Contemplating Genotype-Based Hereditary Hemochromatosis Population Screening.Genes (Basel). 2022 Sep 9;13(9):1622. doi: 10.3390/genes13091622. Genes (Basel). 2022. PMID: 36140790 Free PMC article. Review.
-
Enabling Diagnostic Resulting as a New Category of Secondary Genomic Findings.J Pers Med. 2022 Jan 26;12(2):158. doi: 10.3390/jpm12020158. J Pers Med. 2022. PMID: 35207647 Free PMC article.
-
Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.BMJ. 2019 Jan 16;364:k5222. doi: 10.1136/bmj.k5222. BMJ. 2019. PMID: 30651232 Free PMC article.
-
Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.Genet Med. 2018 Apr;20(4):383-389. doi: 10.1038/gim.2017.121. Epub 2017 Aug 3. Genet Med. 2018. PMID: 28771247 Free PMC article. Review.
-
Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists.Genet Med. 2017 Jan;19(1):112-120. doi: 10.1038/gim.2016.73. Epub 2016 Jun 30. Genet Med. 2017. PMID: 27362912 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical